248 related articles for article (PubMed ID: 11799091)
21. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
22. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
Hollenberg NK; Fisher ND; Price DA; Williams GH
Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
[TBL] [Abstract][Full Text] [Related]
23. Vascular angiotensin-converting enzyme expression regulates local angiotensin II.
Müller DN; Bohlender J; Hilgers KF; Dragun D; Costerousse O; Ménard J; Luft FC
Hypertension; 1997 Jan; 29(1 Pt 1):98-104. PubMed ID: 9039087
[TBL] [Abstract][Full Text] [Related]
24. Renal tissue angiotensin II: response to infusions of angiotensin I and an angiotensin-converting enzyme inhibitor.
Reams G; Villarreal D; Wu Z; Bauer JH
Am J Kidney Dis; 1993 Dec; 22(6):851-7. PubMed ID: 8250032
[TBL] [Abstract][Full Text] [Related]
25. Effects of reduced renal perfusion pressure and acute volume expansion on proximal tubule and whole kidney angiotensin II content in the rat.
Boer WH; Braam B; Fransen R; Boer P; Koomans HA
Kidney Int; 1997 Jan; 51(1):44-9. PubMed ID: 8995716
[TBL] [Abstract][Full Text] [Related]
26. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
27. Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
Lindsey CJ; Bendhack LM; Paiva AC
J Hypertens Suppl; 1987 Jul; 5(2):S71-6. PubMed ID: 2821209
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
Schunkert H; Ingelfinger JR; Jacob H; Jackson B; Bouyounes B; Dzau VJ
Am J Physiol; 1992 Nov; 263(5 Pt 1):E863-9. PubMed ID: 1443118
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-(1--7) in the ovine fetus.
Moritz KM; Campbell DJ; Wintour EM
Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R404-9. PubMed ID: 11208568
[TBL] [Abstract][Full Text] [Related]
31. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
Edling O; Bao G; Feelisch M; Unger T; Gohlke P
J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
Paula RD; Lima CV; Khosla MC; Santos RA
Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
[TBL] [Abstract][Full Text] [Related]
33. Enalaprilat blunts reflexive increases in cardiac interstitial norepinephrine in conscious rats.
Calhoun DA; Wei CC; Zhu S; Bradley WE; Dell'Italia LJ
J Hypertens; 2001 Nov; 19(11):2025-9. PubMed ID: 11677368
[TBL] [Abstract][Full Text] [Related]
34. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.
Ferrario CM; Averill DB; Brosnihan KB; Chappell MC; Iskandar SS; Dean RH; Diz DI
Kidney Int; 2002 Oct; 62(4):1349-57. PubMed ID: 12234305
[TBL] [Abstract][Full Text] [Related]
35. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats.
Navar LG; Lewis L; Hymel A; Braam B; Mitchell KD
J Am Soc Nephrol; 1994 Oct; 5(4):1153-8. PubMed ID: 7849257
[TBL] [Abstract][Full Text] [Related]
36. Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions.
Cervenka L; Mitchell KD; Oliverio MI; Coffman TM; Navar LG
Kidney Int; 1999 Nov; 56(5):1855-62. PubMed ID: 10571794
[TBL] [Abstract][Full Text] [Related]
37. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
Allan DR; Hui KY; Coletti C; Hollenberg NK
J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
[TBL] [Abstract][Full Text] [Related]
38. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
[TBL] [Abstract][Full Text] [Related]
39. Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats.
Mitchell KD; Jacinto SM; Mullins JJ
Am J Physiol; 1997 Aug; 273(2 Pt 2):F246-53. PubMed ID: 9277585
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Nussberger J; Wuerzner G; Jensen C; Brunner HR
Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
